Rare diseases
Investigational molecules
Locations
Durvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer
FranceBisoprolol in Patients After Myocardial Infarction with Preserved Ejection Fraction During Cardiac Rehabilitation
BelgiumBMS-986525 Alone and with Nivolumab in Patients with Relapsed or Refractory Small Cell Lung Cancer
ItalyNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
BulgariaAsciminib in Pediatric Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase
FranceJNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments
FranceNHS7108 for Exocrine Pancreatic Insufficiency in Adult Patients
BulgariaTelisotuzumab Adizutecan for Locally Advanced or Metastatic Solid Tumors with MET Amplification in Patients 12 Years and Older
DenmarkLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
AustriaEIK1005 Alone and with Pembrolizumab for Advanced Solid Tumors in Patients with MSI-H or dMMR Tumors
AustriaAUR200 for Patients with Generalized Myasthenia Gravis
PolandPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
